Truist Financial Sticks to Their Hold Rating for Cross Country Healthcare (CCRN)

Truist Financial analyst Tobey Sommer maintained a Hold rating on Cross Country Healthcare today and set a price target of $10.00.

Claim 50% Off TipRanks Premium and Invest with Confidence

• Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential

Sommer covers the Industrials sector, focusing on stocks such as Robert Half, Clean Harbors, and Heidrick & Struggles. According to TipRanks, Sommer has an average return of 6.8% and a 57.23% success rate on recommended stocks.

In addition to Truist Financial, Cross Country Healthcare also received a Hold from Barrington’s Kevin Steinke in a report issued on December 10. However, on December 4, Citizens JMP upgraded Cross Country Healthcare (NASDAQ: CCRN) to a Buy.

Based on Cross Country Healthcare’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $250.05 million and a GAAP net loss of $4.77 million. In comparison, last year the company earned a revenue of $315.12 million and had a net profit of $2.56 million

Based on the recent corporate insider activity of 23 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of CCRN in relation to earlier this year. Earlier this month, Larry W. Cash, a Director at CCRN bought 5,000.00 shares for a total of $40,788.00.